Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial

Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page updated from v3.6.2 to v3.6.3, indicating a new page release or update rather than a change to study details. This is a metadata-level update and does not alter the study content.
    Difference
    0.0%
    Check dated 2026-07-06T16:15:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2, replacing v3.6.0, indicating a backend/template update without changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-29T10:48:23.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new publication citation related to DESTINY-PanTumor02 was added to Publications, including the authors, journal, DOI, and Epub date; the Online ahead of print note for that citation was removed.
    Difference
    0.0%
    Check dated 2026-06-22T09:24:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Enrollment status updated to indicate recruitment is closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page also shows a revision to v3.6.0 and a removal of the Intervention/Treatment label, reflecting content restructuring.
    Difference
    0.2%
    Check dated 2026-06-15T08:24:33.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.5.4 to v3.5.5, indicating a page patch has been applied. This reflects an internal versioning update rather than a change to the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-08T04:11:56.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new PubMed citation has been added to Publications for DESTINY-PanTumor02, describing antitumor activity and biomarker analyses in HER2-expressing gynecologic cancers. This expands the study's related literature tied to the trial without changing any study details.
    Difference
    0.0%
    Check dated 2026-05-24T14:38:08.000Z thumbnail image

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.